Does SECUKINUMAB Cause Injection site mass? 317 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 317 reports of Injection site mass have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.2% of all adverse event reports for SECUKINUMAB.
317
Reports of Injection site mass with SECUKINUMAB
0.2%
of all SECUKINUMAB reports
1
Deaths
15
Hospitalizations
How Dangerous Is Injection site mass From SECUKINUMAB?
Of the 317 reports, 1 (0.3%) resulted in death, 15 (4.7%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Injection site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 317 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
Which SECUKINUMAB Alternatives Have Lower Injection site mass Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG